GlassScriptPhysician profile
Margaret Keeling
NPI 1356439400
$1,916.86
in general payments reported to CMS, 2019-2025
28 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2021: $113 · 2022: $281 · 2023: $405 · 2024: $296 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $293.98 | 2019-2025 | |
| Astellas Pharma US INC | $274.93 | 2019-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $213.45 | 2022-2025 | Phexxi, Solosec, Phexx |
| Abbott Laboratories | $188.86 | 2019 | |
| Mayne Pharma Commercial LLC | $144.84 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.73 | 2019-2025 | |
| Caldera Medical, INC | $68.38 | 2021 | |
| Smith+Nephew, INC. | $60.75 | 2019-2025 | Pico 14 |
| Meditrina | $57.40 | 2022-2023 | |
| Biogen, INC. | $55.82 | 2024-2025 | Zurzuvae |
| Duchesnay USA Incorporated | $53.36 | 2019 | |
| Lupin INC. | $51.25 | 2019 | |
| Organon LLC | $46.04 | 2022-2023 | Nexplanon |
| Sumitomo Pharma America, INC. | $45.47 | 2023-2025 | Myfembree |
| Allergan, INC. | $45.13 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.17 | 2024 | |
| Merck Sharp & Dohme LLC | $23.79 | 2019 | |
| Hologic Sales and Service, LLC | $19.43 | 2023 | Aptima |
| Cumberland Pharmaceuticals, INC. | $19.19 | 2022 | |
| Optumhealth Care Solutions, LLC | $19.12 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Daiichi Sankyo INC. | $18.41 | 2019 | |
| Coopersurgical, INC. | $17.54 | 2019 | |
| Therapeuticsmd, INC. | $17.00 | 2019 | |
| Becton, Dickinson and Company | $16.98 | 2022 | |
| Albireo Pharma, INC. | $15.48 | 2022 | |
| Mylan Pharmaceuticals INC. | $14.63 | 2019 | |
| Aspira Women'S Health INC | $13.94 | 2024 | Ova1 |
| Boston Scientific Corporation | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Keeling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.